NCT05283993
- Conditions
- Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +44 more
- Locations
-
- Peking University First Hospital Beijing, China
Clinical trial condition
Explore clinical trials studying Monoclonal Gammopathy of Neurological Significance (MGNS). Study availability and eligibility vary by location and protocol.
NCT05283993